SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roudy who wrote (1669)7/14/1999 4:02:00 PM
From: Maurice Winn1 Recommendation  Read Replies (2) of 1762
 
Incidentally, you might recall over a year ago I reported that a doctor at Scripps Clinic told me he had treated people with Rituxan [this was before February 1998] and had had a couple of cases of tuberculosis from it. I'm interested in the infections resulting from the B-cell depletion Rituxan causes. He also said that in a few years, tuberculosis was likely to become a serious threat with treatment options limited. This antibiotic immunity has been widely reported, but I haven't seen much worry about widespread epidemics of tuberculosis.

Have there been reports on these or was this doctor exaggerating about tuberculosis and Rituxan for some reason [perhaps to justify in my mind why he was not offering Rituxan for a CD20 positive intermediate grade NHL]?

All I have seen are the boring old reports of people feeling as though they have a bit of influenza. I recall some time that there were some serious side-effects with treatment stopped in some cases. The side-effects would be interesting. Is there a url?

Maurice
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext